Meatly: The Future of Meat — Sustainable, Healthy, Humane, and Made for the Pets We Love
The global meat industry is one of the largest contributors to climate change, land degradation, and water use. Yet, 20% of all meat produced doesn’t go to human consumption—it goes to pets. This is not only an environmental concern, but also an ethical dilemma for pet owners increasingly conscious of sustainability and animal welfare. Meanwhile, pet food demand is outpacing traditional meat production, raising concerns over long-term supply security for manufacturers and retailers.
Meatly is solving this problem at the cellular level. By taking a single sample of cells from one egg—just once—Meatly can grow an infinite supply of real meat without harming animals. Their cultivated meat uses 99% less land and water, produces 75% fewer CO₂ emissions, and contains no antibiotics. And they’ve already made history: Meatly sold the world’s first cultivated pet food, proving that cultivated meat is not only possible but ready for market.
Greenbackers is proud to introduce Meatly, the company pioneering cultivated meat for pets—with a clear path to human food, massive sustainability impact, and breakthrough production economics that change the game for the entire protein industry.
Why Meatly:
- Innovative technology: Meatly’s patent-pending cultivated meat technology is 99% cheaper than competitors, thanks to a highly efficient, scalable process derived from a single egg cell. It delivers real animal meat without antibiotics, hormones, or environmental damage. Unlike other cultivated meat companies still in R&D, Meatly has already launched a product, proving both viability and scalability.
- Commercial traction: Meatly has sold the world’s first cultivated pet food—a global first—and has done so with just 1% of the investment raised by other players, moving 5x faster from concept to market. The company has Letters of Intent covering 4x the capacity of its pilot facility, and has secured investment from leading pet food manufacturers and retailers.
- Market potential: Pet food accounts for 20% of global meat consumption, placing immense strain on traditional meat production. As demand continues to outpace supply, cultivated meat offers a timely, scalable solution. Meatly is uniquely positioned to meet this need now, with a B2B model targeting pet food manufacturers through a fast-moving, regulatory-light channel. Meatly plans to enter the human food market by 2027 and license its technology to partners across the cultivated meat and biopharma sectors—unlocking multiple high-growth revenue streams and expanding its impact across industries.
Investment Snapshot:
- Type: Series A
- Target amount: £12.5m
- Minimum contribution: £50,000
Meatly is on a mission to make meat better—for the planet, for animals, and for the future of food. This is cultivated meat, done right—starting with pets, and scaling far beyond.
For further information or to speak with Meatly directly contact Annika Borrmann at annika@greenbackers.com
